Ultravist™ by Bayer now approved for contrast-enhanced mammography in EU
Not intended for U.S. and UK Media Berlin, January 23, 2023 – Bayer announced today that its iodine-based contrast agent Ultravist™-300, -370 is now approved for contrast-enhanced mammography (CEM) in the EU. The product can be used to evaluate and detect lesions of the breast as an adjunct to mammography (with or without ultrasound) or …
Ultravist™ by Bayer now approved for contrast-enhanced mammography in EU Read More »